|
The People
Clinical Advisors
Kenneth L.N. Blocka, MD
Dr. Kenneth Blocka is a Clinical Professor at the University of British Columbia,
as well as Clinical Head of the Division of Rheumatology at St. Paul’s Hospital
with which he has an affiliation through his full-time rheumatology practice. Dr.
Blocka graduated from the University of Saskatchewan, School of Medicine and completed
his post-graduate and sub-specialty training at the University of Saskatchewan and
University of Toronto followed by a Clinical Fellowship in Rheumatology at the University
of California Los Angeles. He then returned to assume a full time academic position at
the University of Saskatchewan rising to the rank of Clinical Professor as well as Head
of the Division of Rheumatology. In addition to pursuing clinical research, Dr. Blocka
has a major interest in undergraduate and postgraduate education and served for a number
of years both as a Member as well as Chairman of the Royal College Examination Committee
for Rheumatology.
Walter P. Maksymowych, MD
Dr. Walter Maksymowych, is a Professor in the Department of Medicine, Division
of Rheumatology at the University of Alberta. He is also a Senior Scholar of the
Alberta Heritage Foundation for Medical Research, a member of the Canadian
Arthritis Network Centres of Excellence, advisory board member of the Assessments
in Ankylosing Spondylitis International Working Group, and Scientific Chair of the
Alberta Rheumatoid Arthritis and Pharmacovigilance Program and Outcomes Research
in Therapeutics (RAPPORT) committee. He has served on the Task Force for the FDA
Industry Guidance Document for Clinical Trials in Ankylosing Spondylitis. He is
past-Chair of the Scientific Committee of the Canadian Rheumatology Association,
and past-Chair of the Medical Advisory Board of the Spondylitis Association of
America and the American College of Rheumatology Spondyloarthropathy Study Group.
Dr. Maksymowych graduated from the University of Manchester School of Medicine,
United Kingdom and completed his postgraduate training at the University of
Edmonton and the Children’s Hospital Medical Center, Cincinnati, Ohio. He
holds Fellowships in the Royal College of Physicians of Canada, the American
College of Physicians, and the Royal College of Physicians of the UK. He has
authored over one hundred peer-reviewed papers as well as numerous abstracts and
book chapters, and has been invited to speak at both national and international
meetings. His primary research interests are advanced therapeutics, ankylosing
spondylitis and other sero-negative spondyloarthropathies, rheumatoid arthritis,
and the genetics of arthritis.
Kam Shojania, MD
Dr. Kam Shojania is a Clinical Associate Professor and the Head of the Division of
Rheumatology, Faculty of Medicine at University of British Columbia (UBC), where he
also holds the position of Rheumatology Postgraduate Program Director. Dr. Shojania
has been in rheumatology practice since 1995 and is on staff at St. Paul’s
Hospital and Vancouver General Hospital. Dr. Shojania is an investigator at the
Arthritis Research Centre of Canada (ARC) in Vancouver and is the former Director
of Clinical Trials at ARC. He was a founding member and Director of the Canadian
Rheumatology Research Consortium and is involved in several ongoing clinical trials
in the areas of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus
and ankylosing spondylitis. Dr. Shojania’s former positions and previous awards
include Medical Director of the Vancouver Pain Clinic, the Director of Continuing
Medical Education in the UBC Division of Rheumatology and he was the recipient of a
Clinician-Teacher Award from The Arthritis Society and received a UBC Faculty of
Medicine Award for Excellence in Teaching. He is a graduate from the UBC medical
school where he also completed his specialty training in Internal Medicine and
his fellowship in Rheumatology. Dr. Shojania has an interest and is published in
the area of laboratory testing of the rheumatic diseases.
|
